idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Klaus Faber Foundation supports successful call defence of Prof Olga Kalinina by HIPS and Saarland University
In the context of the tenure negotiations for Drug Bioinformatics Professor Olga Kalinina, the Klaus Faber Foundation is providing €100,000 to the "bioINFpro" project, thereby enabling her long-term stay at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University. Since 2018, Prof Kalinina, as a Klaus Faber Foundation Professor, has been involved in bioinformatic research on new drugs against infectious diseases. The confirmation of project funding took place on November 6, 2023, on the campus of Saarland University. HIPS is a site of the Helmholtz Centre for Infection Research in cooperation with Saarland University.
With additional funding of €100,000, the Klaus Faber Foundation supports Kalinina's project "bioINFpro," which aims to expand drug research through AI-based methods and develop new antibiotics against antibiotic-resistant bacteria. In doing so, the foundation makes a significant contribution to retaining Kalinina at the Saarbrücken site, despite an attractive offer from Heidelberg University. When Kalinina was appointed jointly by Saarland University and HIPS at the end of 2018, she was the first scientist at HIPS whose group was explicitly dedicated to bioinformatic research. Since then, the number of groups in the field of bioinformatics at HIPS has grown to five with additional funding from federal and state sources.
Elena Yorgova-Ramanauskas, State Secretary in the Ministry of Economic Affairs, Innovation, Digitalization and Energy, honors the extraordinary commitment of the Klaus Faber Foundation: “The state government has continuously supported the HIPS since it was founded and I am very pleased that other stakeholders also recognise the potential of the HIPS and acknowledge its outstanding achievements. Thanks to the generous support of the Klaus Faber Foundation, it has been possible to bundle the expertise of the HIPS together with Saarland University in the important field of drug bioinformatics in an endowed professorship, which has undoubtedly developed into a success story with the appointment of Prof Kalinina. The renewed support will make a significant contribution to continuing this success story.“
"The outstanding scientific work of HIPS was crucial for the Klaus Faber Foundation's commitment in 2018 to engage in funding and, at the suggestion of Prof Müller, to participate in the establishment of the endowed professorship for Drug Bioinformatics in cooperation with Saarland University. Since then, both HIPS as a whole and the now broadly established focus on bioinformatics have experienced a tremendous development. On behalf of the Klaus Faber Foundation, we are pleased to continue supporting the excellent work at HIPS through our initiative bioINFpro," says Dr Andreas Schmitt, Board Member of the Klaus Faber Foundation.
"The funding of the endowed professorship for Drug Bioinformatics by the Klaus Faber Foundation allowed us to lay a foundation in this now indispensable field of drug research. In the following years, we were able to make bioinformatics a core topic of the institute and attract numerous new, excellent groups to the site. Without the support of the Klaus Faber Foundation, this would not have been possible in this form," says Prof Rolf Müller, Scientific Director of HIPS.
"With the Klaus Faber Endowed Professorship for Drug Bioinformatics, Saarland University and HIPS can continue their highly successful interdisciplinary collaboration at the interface of two research focal points on campus - bioinformatics and pharmaceutical research. The research work of bioinformatician Olga Kalinina will further advance drug development through AI-based methods and significantly strengthen this research area in Saarbrücken," comments Prof Veit Flockerzi, Vice President for Research at Saarland University.
At the end of 2018, bioinformatician Olga Kalinina was appointed Professor for Drug Bioinformatics at the Center for Bioinformatics (ZBI) at Saarland University and has since also led the group of the same name at HIPS. Her professorship is located in the medical faculty of the university to deliberately strengthen the interaction between computer science and medicine. The basis for the newly established endowed professorship was funding from the Klaus Faber Foundation in the amount of €1.6 million over a period of five years. In her research, Kalinina develops bioinformatic methods to model biological processes on a computer and applies them - for example, to understand how antibiotics and bacteria interact with each other on a molecular level. She also investigates how antibiotic resistance develops and what role genetic factors play.
The confirmation of project funding by the Klaus Faber Foundation took place on November 6, 2023, during a festive event at the presidium of Saarland University.
This press release is also available on our homepage: https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/staerkung....
Helmholtz Institute for Pharmaceutical Research Saarland:
The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken was founded jointly by the Helmholtz Centre for Infection Research and Saarland University in 2009. The researchers at HIPS are particularly researching new active substances against infectious diseases, optimising them for use in humans and investigating how they can best be transported to their site of action in the human body. http://www.helmholtz-hips.de
Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and other locations in Germany study bacterial and viral infections and the body's defence mechanisms. They have in-depth expertise in natural product research and its use as a valuable source for novel anti-infectives. As a member of the Helmholtz Association and the German Centre for Infection Research (DZIF), the HZI conducts translational research to lay the foundations for the development of novel therapies and vaccines against infectious diseases. http://www.helmholtz-hzi.de/en/
Contact:
Dr Yannic Nonnenmacher
PR Manager HIPS
+49 681 98806-4500
yannic.nonnenmacher@helmholtz-hips.de
Confirmation of the project funding by the Klaus Faber Foundation.
HIPS
Merkmale dieser Pressemitteilung:
Journalisten, Studierende, Wirtschaftsvertreter, Wissenschaftler
Biologie, Chemie, Informationstechnik, Medizin
überregional
Personalia, Wissenschaftspolitik
Englisch
Confirmation of the project funding by the Klaus Faber Foundation.
HIPS
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
